T. Dempsey

Mayo Clinic

Poster Author Of 2 e-Posters

 ePosters
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A5920 - Adoption of the Anti-Fibrotic Medications Pirfenidone and Nintedanib Among Commercially-Insured Adults in the United States

Presenter:
Date
05/22/2019
Room
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown
Session Name
D22 - REAL WORLD MEDICATION USE IN PULMONARY DISEASES
Session Type
RAPiD: Rapid Abstract Poster Discussion Session
Authors
12. Diffuse Parenchymal Lung Diseases: ILD, Sarcoidosis, IPF, LAM

A7393 - Mortality Effect of the Anti-Fibrotics Pirfenidone and Nintedanib in Clinical Practice

Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C35 - HEALTH SERVICES RESEARCH IN COUGH, CF, AND ILD
Session Type
Thematic Poster Session
Authors